Types of Hyperuricemia in Toraja Tribe: a cross-sectional study
Keywords:
Hyperuricemia, uric acid, underexcretion, overproductionAbstract
Background and aim: The study investigates the incidence and types of hyperuricemia among the Toraja ethnic group. It aims to understand the relationship between their dietary habits and the risk factors associated with hyperuricemia.
Methods: This research employed a cross-sectional design, collecting primary data through random uric acid level examinations and history taking in Makassar, Indonesia. We classified hyperuricemia into overproduction, underexcretion, or a combination of both.
Results: Most participants were male (59%) and predominantly aged around 40 years, with most having good nutritional status. The most common type of hyperuricemia identified in the Toraja population was underexcretion.
Conclusions: The findings of this study indicate that the most common type of hyperuricemia among the Toraja population is the under-excretion type. This suggests that most individuals in this population have difficulty excreting uric acid, which a purine-rich diet, such as red meat and alcoholic beverages, may influence. These findings highlight the importance of understanding dietary and lifestyle factors that contribute to elevated uric acid levels and the need for special attention to the health of the Toraja community.
References
George C, Leslie SW, Minter DA. Hyperuricemia. In: StatPearls. StatPearls Publishing; 2024. Accessed November 13, 2024. http://www.ncbi.nlm.nih.gov/books/NBK459218/
Skoczyńska M, Chowaniec M, Szymczak A, Langner-Hetmańczuk A, Maciążek-Chyra B, Wiland P. Pathophysiology of hyperuricemia and its clinical significance – a narrative review. Rheumatology. 2020;58(5):312-323. doi:10.5114/reum.2020.100140
Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8-14. doi:10.1016/j.ijcard.2015.08.109
Benn CL, Dua P, Gurrell R, et al. Physiology of Hyperuricemia and Urate-Lowering Treatments. Front Med. 2018;5:160. doi:10.3389/fmed.2018.00160
Choi ST, Song JS, Kim SJ, Kim CH, Moon SJ. The Utility of the Random Urine Uric Acid-to-Creatinine Ratio for Patients with Gout Who Need Uricosuric Agents: Retrospective Cross-Sectional Study. J Korean Med Sci. 2020;35(13):e95. doi:10.3346/jkms.2020.35.e95
Qi H, Sun M, Terkeltaub R, et al. Response to febuxostat according to clinical subtypes of hyperuricemia: a prospective cohort study in primary gout. Arthritis Res Ther. 2023;25(1):241. doi:10.1186/s13075-023-03228-y
Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. Int J Mol Sci. 2021;22(17):9221. doi:10.3390/ijms22179221
Kurniari PK, Kambayana G, Raka Putra T. Hubungan hiperurisemia dan fraction uric acid clearance di desa Tenganan Pegringsingan Karangasem Bali. J Penyakit Dalam. 2021;12(2):77-80.
Yadav S, Bhosale M, Sattigeri B, Vimal S. Pharmacological overview for therapy of gout and hyperuricemia. Int J Health Sci. Published online May 4, 2022:7772-7785. doi:10.53730/ijhs.v6nS2.6926
Ichida K, Matsuo H, Takada T, et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun. 2012;3(1):764. doi:10.1038/ncomms1756
Juraschek SP, Yokose C, McCormick N, Miller ER, Appel LJ, Choi HK. Effects of Dietary Patterns on Serum Urate: Results From a Randomized Trial of the Effects of Diet on Hypertension. Arthritis Rheumatol Hoboken NJ. 2021;73(6):1014-1020. doi:10.1002/art.41614
Raya-Cano E, Vaquero-Abellán M, Molina-Luque R, De Pedro-Jiménez D, Molina-Recio G, Romero-Saldaña M. Association between metabolic syndrome and uric acid: a systematic review and meta-analysis. Sci Rep. 2022;12(1):18412. doi:10.1038/s41598-022-22025-2
Richette P, Bardin T. Gout. The Lancet. 2010;375(9711):318-328. doi:10.1016/S0140-6736(09)60883-7
FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res. 2020;72(6):744-760. doi:10.1002/acr.24180
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Munaiva Syahrir, Faridin H. Pango, Hasyim Kasim, Wasis Udaya, Syakib Bakri, Andi Alfian Zainuddin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
